Back
Tango Therapeutics Quote, Financials, Valuation and Earnings
Better Than Oil Stocks
CLICK HERE TO FIND OUT MORE
Buy
54
TNGX
Tango Therapeutics
Last Price:
3.10
Seasonality Move:
0.06%
7 Day Trial
ALL ACCESS PASS
$
7
Zero Day Options Trade LIVE Tuesday at 2 p.m. ET!
Discover The Zero Day Loophole (BEFORE Tues at 2 p.m. ET!)Tango Therapeutics Price Quote
$3.10
-0.21 (-6.34%)
(Updated: December 11, 2024 at 5:55 PM ET)
Tango Therapeutics Key Stats
Buy
54
Tango Therapeutics (TNGX)
is a Buy
Day range:
$3.13 - $3.37
52-week range:
$2.70 - $13.01
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
8.19
P/B ratio:
1.55%
Volume:
1.1M
Avg. volume:
2.7M
1-year change:
-63.94%
Market cap:
$355.6M
Revenue:
$36.5M
EPS:
$-1.16
How Much Does Tango Therapeutics Make?
-
How Much Are Tango Therapeutics's Sales Annually?
TNGX Revenues are $36.5M -
How Much Profit Does Tango Therapeutics's Make A Year?
TNGX net income is -$101.7M
Is Tango Therapeutics Growing As A Company?
-
What Is Tango Therapeutics's Growth Rate Quarterly?
Quarterly YoY revenue growth is 0.08% -
What Is Tango Therapeutics's EPS Quarterly YoY Growth Rate?
Quarterly, year-over-year diluted EPS growth rate is 0%
Tango Therapeutics Stock Price Performance
-
Did Tango Therapeutics Stock Go Up Last Month?
Tango Therapeutics share price went up by 12.2% last month -
Did TNGX's Share Price Rise Over The Last Year?
TNGX share price fell by -63.94% over the past 1 year
What Is Tango Therapeutics 52-Week High & Low?
-
What Is Tango Therapeutics’s 52-Week High Share Price?
Tango Therapeutics has traded as high as $13.01 over the past 52 weeks -
What Is Tango Therapeutics’s 52-Week Low Share Price?
Tango Therapeutics has traded as low as $2.70 over the past 52 weeks
Tango Therapeutics Price To Free Cash Flow
Data Unavailable
Is It Risky To Buy Tango Therapeutics?
-
How Much Debt Does Tango Therapeutics Have?
Total long term debt quarterly is $0 -
How Much Cash Does Tango Therapeutics Have?
Cash and short term investments quarterly total is $293.3M -
What Is Tango Therapeutics’s Book Value Per Share?
Book value per share is 2.13
Is Tango Therapeutics Cash Flow Positive?
-
What Is TNGX Cash Flow From Operations?
Cash flow from operations (TTM) is -$122.3M -
What Is Tango Therapeutics’s Cash Flow From Financing?
Cash flow from financing (TTM) is $48.2M -
What Is Tango Therapeutics’s Cash Flow From Investing?
Cash flow from investing (TTM) is $67.9M
Tango Therapeutics Return On Invested Capital
-
Is Management Doing A Good Job?
TNGX return on invested capital is -48.54% -
What Is Tango Therapeutics Return On Assets?
ROA measures how assets are converting to revenues and is -31.31% -
What Is TNGX Return On Equity?
ROE is a measure of profitability and is -48.54%
Tango Therapeutics Earnings Date & Stock Price
-
What Is Tango Therapeutics's Stock Price Today?
A single share of TNGX can be purchased today for 3.31 -
What Is Tango Therapeutics’s Stock Symbol?
Tango Therapeutics trades on the nasdaq under the ticker symbol: TNGX -
When Is Tango Therapeutics’s Next Earnings Date?
The next quarterly earnings date for Tango Therapeutics is scheduled on March 18, 2025 -
When Is TNGX's next ex-dividend date?
Tango Therapeutics's next ex-dividend date is December 12, 2024 -
How To Buy Tango Therapeutics Stock?
You can buy Tango Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
Tango Therapeutics Competitors
-
Who Are Tango Therapeutics's Competitors?
Below is a list of companies who compete with Tango Therapeutics or are related in some way:
Tango Therapeutics Dividend Yield
-
What Is TNGX Dividend Yield?
Tango Therapeutics’s dividend yield currently is 0% -
What Is Tango Therapeutics’s Payout Ratio?
Tango Therapeutics’s payout ratio is 0% -
When Did Tango Therapeutics Last Pay A Dividend?
The latest dividend pay date is December 12, 2024 -
What Is Tango Therapeutics’s Dividend Per Share?
Tango Therapeutics pays a dividend of $0.00 per share
Tango Therapeutics Analyst Estimates
| YoY Growth | Past Surprise | |
|---|---|---|
| EPS: | 0% | 27.94% |
| Revenue: | 8.15% | 43.9% |
Analyst Recommendations
| Buy Recommendations: | 6 |
|---|---|
| Hold Recommendations: | 0 |
| Sell Recommendations: | 0 |
| Price Target: | 11.50 |
| Upside from Last Price: | 247.43% |